Development and validation of a HPLC method for the determination of sertraline and three non-chiral related impurities.
ABSTRACT In this study, a screening on reversed-phase stationary phases (including C(8), C(18), CN, PEG and amide) was carried out in order to obtain an efficient HPLC method for the determination of sertraline and three of its more closely related synthetical and non-chiral impurities, without using ion-pair reagents. The best results in terms of both retention time and resolution of the target analytes were obtained with a Zorbax Bonus-RP column, which contains a polar amide group embedded in a C(14) alkyl chain. Once the most suitable stationary phase was chosen, the HPLC method was optimized by using a factorial design, evaluating three quantitative factors (column temperature, buffer pH and buffer concentration) in order to find the best conditions which maximize the resolution between impurities A and B (positional isomers) and minimize the total run time. The final HPLC conditions were set by means of a second experimental design, which allowed optimizing the effects of the buffer pH and the proportion of methanol in the mobile phase. The optimal conditions for simultaneously determining sertraline and its impurities, being baseline separated in less than 10 min, were finally obtained with Zorbax Bonus-RP column (150 mmx4.6mm, 5 microm), under isocratic conditions with phosphate buffer (pH 2.8; 10mM)-methanol (63:37, v/v) at 50 degrees C, at the flow-rate of 1.0 mL/min. UV detection was set at 220 nm. This method was successfully validated following ICH guidelines and it proved to be reliable for the determination of sertraline and related impurities in tablets as pharmaceutical forms.
- SourceAvailable from: Krishnasarma pathy/ SARMA KRISHNA PATHY[Show abstract] [Hide abstract]
ABSTRACT: HPLC method development and validation play important role in the discovery, development and manufacture of agro chemicals , pharmaceutical products. This article mainly focuses on the optimization of HPLC conditions and other important perspectives during method development and validation. Various critical steps related to analytical method development and validation is discussed. A sequence of events required for method development and analytical validation are described. The steps involved in developing a stability-indicating HPLC method influences the analysis of degradation products/impurities in stability study and its validation demonstrate the suitability for its intended purpose.High Performance Liquid Chromatography (HPLC) is one of the most widely used analytical techniques in industry. It is used to separate and analyse compounds through the mass-transfer of analytes between stationary and mobile phases1-3. The technique is employed in a broad range of activities, such as the analysis of foods, drugs and agrochemicals. The technique of HPLC utilises a liquid mobile phase to separate the components of a mixture. The components themselves are first dissolved in a solvent and then forced to flow (via the mobile phase) through a column (stationary phase) under highpressure. The mixture is resolved into its components within the column and the amount of resolution is dependent upon the interaction between the solute components and the column stationary phase (immobile packing within the column) and liquid phase. The interaction of the solute with the mobile and stationary phases can be manipulated through different choices of both solvent and stationary phasesRESARCHGATE. 05/2013;
- Chromatographia 10/2014; 77(19-20):1315-1321. · 1.37 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Liquid chromatography (LC) is a separation technique used in many different areas to aid the identification and quantification of substances in various matrices. LC techniques with various detection modes have been widely used for the sensitive and selective determination of trace amounts of pharmaceutical active compounds in biological samples and their dosage forms. A completely new system design with advanced technology has been developed, called ultra high performance liquid chromatography, which has evolved from high performance liquid chromatography. The application of LC methods to drug analysis introduces a powerful tool for therapeutic drug monitoring as well as for clinical research. The advantages of short turnaround time, method reliability, method sensitivity, and drug specificity justify the use of LC techniques for various groups of the drug active compounds. This review describes some of the principles of ultra high performance liquid chromatography and high performance liquid chromatography, validation of these methods, system suitability tests for the methods, and application of methods to pharmaceutical analysis in the last 3 years.Chromatographia 11/2013; · 1.37 Impact Factor